KEWAUNEE SCIENTIFIC CORP /DE/ KEQU
Nasdaq · stock · Laboratory Apparatus & Furniture · website · IPO 1980-03-17
KEWAUNEE SCIENTIFIC CORP /DE/ financials (annual)
Bars are annual figures from 2017 to 2026; red bars are negative (a loss or cash outflow).
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.0M | $240.5M | $203.8M | $219.5M | $168.9M | $147.5M | $147.5M | $146.6M | $158.1M | $138.6M |
| Gross profit | $80.4M | $68.9M | $52.1M | $35.6M | $24.2M | $24.0M | $23.4M | $25.3M | $32.2M | $26.6M |
| R&D expense | $898,000 | $919,000 | $920,000 | $1.0M | $990,000 | $1.4M | $1.8M | $1.6M | $1.5M | $1.2M |
| Operating income | $16.7M | $17.8M | $18.3M | $5.4M | -$2.6M | -$1.3M | -$2.3M | $2.1M | $9.9M | $6.5M |
| Interest expense | — | — | $1.8M | $1.7M | $632,000 | $389,000 | $493,000 | $367,000 | $299,000 | $292,000 |
| Income tax | $3.3M | $3.2M | -$5.9M | $3.1M | $3.5M | $990,000 | $1.8M | $446,000 | $4.2M | $2.1M |
| Net income | $9.6M | $11.4M | $18.8M | $738,000 | -$6.1M | -$3.7M | -$4.7M | $1.5M | $5.3M | $4.5M |
| EPS (diluted) | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 | $-1.70 | $0.55 | $1.90 | $1.66 |
| Operating cash flow | $18.6M | $14.8M | $19.6M | -$3.8M | -$7.9M | $912,000 | $4.2M | $2.5M | $3.2M | $11.7M |
| Cash & equivalents | $9.9M | $14.9M | $23.3M | $8.1M | $4.4M | $5.2M | $4.4M | $10.6M | $9.7M | $12.5M |
| Inventory | $30.5M | $32.8M | $20.7M | $21.9M | $23.8M | $16.5M | $15.3M | $17.2M | $18.5M | $14.9M |
| Total assets | $178.3M | $194.7M | $134.8M | $118.9M | $118.8M | $89.4M | $83.9M | $87.2M | $85.1M | $80.9M |
| Total liabilities | $101.5M | $128.4M | $78.6M | $80.4M | $82.6M | $47.9M | $45.2M | $39.5M | $36.9M | $37.7M |
| Shareholders' equity | $76.8M | $66.2M | $56.2M | $38.5M | $36.2M | $41.5M | $38.7M | $47.7M | $48.2M | $43.5M |
Growth · year-over-year · Revenue CAGR 8.2%
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +17.3% | +18.0% | -7.2% | +30.0% | +14.5% | -0.0% | +0.7% | -7.3% | +14.1% | +7.7% |
| Net income growth | -15.7% | -39.2% | +2441.1% | — | — | — | -406.5% | -71.0% | +17.0% | +18.8% |
| EPS growth | -15.9% | -40.0% | +2452.0% | — | — | — | -409.1% | -71.1% | +14.5% | +16.9% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2026-04-30. Facts plus Stocktoria's own computed scores — not investment advice.